Transurethral Resection of The Prostate Market
Report ID: SQMIG35A3229
Report ID: SQMIG35A3229
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35A3229 |
Region:
Global |
Published Date: February, 2026
Pages:
157
|Tables:
119
|Figures:
77
Global Transurethral Resection of the Prostate Market size was valued at USD 980.4 Million in 2024 and is poised to grow from USD 1031.38 Million in 2025 to USD 1547.19 Million by 2033, growing at a CAGR of 5.2% during the forecast period (2026-2033).
Transurethral resection of the prostate market is driven primarily by demographic shifts toward older male populations and rising incidence of benign prostatic hyperplasia, which together increase demand for surgical intervention. As a core endoscopic procedure for relieving urinary obstruction, the market matters because it represents both a standard of care and a platform for adjacent device innovation.
Building on that technological momentum, the factor propelling global TURP demand is innovation in energy platforms and perioperative workflows because improved devices reduce complications and shorten recovery, encouraging wider clinician adoption. As bleeding and TUR syndrome risks declined, more centers transitioned procedures to day surgery settings, which lowered costs and increased throughput; hospitals in Europe and North America report shorter catheterization times and same day discharges as common outcomes. Consequently, manufacturers can capture value by bundling consumables while funding training and proctoring programs, enabling expansion into emerging markets where upgrading from open surgery yields measurable cost-effectiveness and scalable health benefits.
How is AI Transforming Surgical Precision in the Transurethral Resection of the Prostate Market?
The transurethral resection of the prostate market by improving real time guidance and intraoperative decision support. Key aspects include better lesion of localization of prostate anatomy and instrument tracking that reduces operator variability. The current state shows clinicians combining preoperative MRI with live ultrasound and AI driven models to translate diagnostic images into actionable targets. These tools integrate with navigation to make resections more consistent and tissue sparing. The result is a shift toward safer, less invasive interventions and smoother workflows for surgical teams.
Market snapshot - 2026-2033
Global Market Size
USD 980.4 Million
Largest Segment
Consumables and Accessories
Fastest Growth
Laser Instruments
Growth Rate
5.2% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global transurethral resection of the prostate market is segmented into product type, technology, application, end user, and region. Based on product type, the market is segmented into monopolar resectoscope, bipolar resectoscope, laser instruments, and consumables and accessories. Based on technology, the market is segmented into monopolar technology, bipolar technology, and laser technology. Based on application, the market is segmented into benign prostatic hyperplasia (BPH), and others. Based on end user, the market is segmented into hospitals, ambulatory surgical centers, urology clinics, and specialty clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
As per transurethral resection of the prostate market outlook, the bipolar resectoscope segment leads the way because of the combination of the safety profile of the device and the compatibility with saline irrigation, which allows for lower-risk surgical approaches to large prostates whereby surgeons can treat larger-sized prostates with lower bleeding and improved visibility. This technical advantage has led to more urologists and hospitals adopting the bipolar resectoscope; thus, driving preference for procurement and clinical guideline endorsements. Additionally, this has resulted in a continuous demand for the device due to clinicians looking for devices that reduce complications, decrease recovery time, and allow for easy integration into existing electrosurgical workflows all reinforcing the leadership position within this segment of the market.
As per transurethral resection of the prostate market forecast, laser instruments are the most rapidly expanding area because their minimally invasive profile, precision tissue ablation, and reduced bleeding encourage adoption across diverse practice settings. As new advancements are made in terms of laser platforms and laser procedural protocols, there will be additional applications of lasers in treating larger prostates and complicated cases; therefore, investing in laser devices will also- provide exciting future opportunities for new manufacturers entering into this large, fast-growing industry.
Hospitals dominate the market with large transurethral resection of the prostate market share because they have integrated multi-disciplinary infrastructure, provided advanced perioperative support, and had a high surgical throughput that typically accommodate complex transurethral resections while managing complications associated with those procedures. By establishing referral pathways and developing rapport and familiarity with clinicians for performing procedures, procedure volumes become much more consistent, and clinicians can invest in specialized resection systems for performing these types of procedures and training staff to use them.
As per transurethral resection of the prostate market analysis, ambulatory surgical centers are growing more quickly than any other setting because they have streamlined workflows, lower overhead, and customized perioperative pathways that enable same-day transurethral resections to be performed. Increasing clinician preference for outpatient procedures along with investment in portable resection technologies and targeted reimbursement models is resulting in increased adoption of these technologies and will provide opportunities for both specialized providers and equipment suppliers.
To get detailed segments analysis, Request a Free Sample Report
As per transurethral resection of the prostate market regional outlook, dominance in North America comes from a convergence of strengths in three areas: clinical, commercial, and regulatory. There is a dense geographic area where the majority of leading device manufacturers and specialty hospitals operate; therefore, they are able to quickly move innovative ideas into practice using the reimbursement system and established procurement channels. There are many collaborative networks among academic institutions, industry partners, and professional societies producing a wealth of evidence and robust training programs that improve clinician utilization of new methods and products. Furthermore, investment in research and development, along with a positive regulatory environment, facilitates entry into the market and provides post-market surveillance.
Transurethral resection of the prostate market in the U.S. is comprised of a mature ecosystem of academic urological institutions, specialized hospitals, and active device manufacturers. There is considerable evidence from the large number of clinical trials and on going educational opportunities for clinicians to improve upon the techniques and devices being used for TURP. The presence of established purchasing channels and strategic partnerships between companies and clinicians provides manufacturers with an opportunity to provide the latest device technology early in the process.
The transurethral resection of the prostate market in Canada has a health system that provides equitable access, consistent pathways for providing care and standard procedures. Centralized policy decision making and provincial procurement strategies that emphasize value and outcome tend to influence uptake/adoption of TURP. Major clinical centers with sufficient volumes of TURP procedures are in urban areas and provide concentrated expertise and training opportunities, which facilitate collaboration between hospitals (or other health delivery organizations) and manufacturers in the assessment of TURP technology and its rollout. The procurement system in Canada allows for a balanced approach between widespread uptake of innovation (i.e., TURP) and the thorough evaluation of TURP’s safety and efficacy.
As per transurethral resection of the prostate market regional forecast, factors contributing to the rapid growth of TURP in Europe include improved models and coordination of care, excellent clinical networks and a growing emphasis on the utilization of minimally invasive treatment of urological conditions. Centralized procurement and public reimbursement in many European markets support structured adoption of TURP as clinical value is established. Clinical research continues to be conducted at a robust level in both academic hospitals and through collaborative multicenter projects, which generates real-world evidence of efficacy/safety and subsequently informs national guidelines and clinician practice.
Transurethral resection of the prostate market in Germany has a lot of strength due to advanced hospital infrastructure and a good amount of specialization in urology. The urology departments are focusing on advancing and adopting new devices with the support of strong ties to manufacturers.
The UK transurethral resection of the prostate market is growing rapidly, driven by targeted policy initiatives and inclusion of innovations in care. Regional centers are being developed both from the public and private sectors to help get faster access to spread the use of practices endorsed by clinical guidelines used by urologists. The investment in the training of the multi-disciplinary team will lead to greater confidence in the newer ways to perform procedures associated with TURA. The use of procurement strategies that balance clinical outcomes with cost will encourage the widespread acceptance of TURA use in hospitals and promote the rapid delivery of the services associated with TURA and the associated technologies for the procedures.
The transurethral resection of the prostate market in France is evolving with hospitals being modernized and a greater emphasis on evidence-based care in urologic medicine. The urban academic medical centres are leading to adoption of new devices and generating clinical data to support their broader use. The pathway of reimbursement/approval is changing to more easily accommodate innovation, and an aggressive effort is being made to standardize the availability of procedures across regions with concerted training activities.
As per transurethral resection of the prostate industry analysis, the Asia Pacific region is enhancing its position through strategic investment in healthcare infrastructure, manufacturing capacity, and training of clinicians in procedural capabilities that encourage the adoption of advanced resection technology through the enhancement of minimally invasive urology services as a major priority by regional governments and private healthcare providers. These partnerships enable technology transfer of technology between global manufacturers and their local partners to provide tailored solutions for varying care environments.
Japan has developed a sophisticated and rigorous regulatory framework for the treatment of transurethral resection of the prostate in conjunction with its developed healthcare system. Institutions with physician-led specialty urology centers promote precision in practice, as well as assessment of outcomes. Japan has an extensive domestic manufacturer network that is part of a thriving network. Japan has implemented rigorous regulatory requirements on health technology assessments; therefore, there is a deliberate pathway to the adoption of advanced surgical techniques.
South Korea has an advanced hospital sector that provides an integrated system of care between all phases of hospital care and diagnosed patients within the continuum of care. As early adopters, both private and government hospitals are heavily involved in collaboration with the developers of devices used in Transurethral Resection of the Prostate, as well as through the provision of training programs. The highly competitive healthcare equipment market in South Korea drives rapid evolution and modification of solutions to meet local clinical workflows.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Aging Population and BPH Prevalence
High Procedure Costs and Reimbursement
Complication Risks and Outcomes
Request Free Customization of this report to help us to meet your business objectives.
Competition in the global transurethral resection of the prostate market is intensifying as incumbents and new entrants compete on minimally invasive substitutes, image guided robotics and office based therapies, driving M&A, strategic partnerships and targeted tech launches. Recent concrete moves include major acquisitions to add minimally invasive platforms, capital raises to scale robotic waterjet therapy, and commercialization of MRI guided transurethral ultrasound systems.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global transurethral resection of the prostate industry is driven by an aging population and rising benign prostatic hyperplasia prevalence, while advances in surgical technologies that improve safety and enable outpatient workflows act as a second important driver. However, high procedure costs and uneven reimbursement represent a major restraint that can slow device adoption and service expansion. North America remains the dominating region due to concentrated device manufacturers, supportive reimbursement and strong clinical networks, and the bipolar resectoscope segment is the dominating product choice because of its improved safety profile and saline irrigation compatibility. Opportunities center on training, bundled consumables, and ambulatory care expansion.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 980.4 Million |
| Market size value in 2033 | USD 1547.19 Million |
| Growth Rate | 5.2% |
| Base year | 2024 |
| Forecast period | 2026-2033 |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Transurethral Resection of The Prostate Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Transurethral Resection of The Prostate Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Transurethral Resection of The Prostate Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Transurethral Resection of The Prostate Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Transurethral Resection Of The Prostate Market size was valued at USD 980.4 Million in 2024 and is poised to grow from USD 1031.38 Million in 2025 to USD 1547.19 Million by 2033, growing at a CAGR of 5.2% during the forecast period (2026-2033).
Competition in the global transurethral resection of the prostate market is intensifying as incumbents and new entrants compete on minimally invasive substitutes, image guided robotics and office based therapies, driving M&A, strategic partnerships and targeted tech launches. Recent concrete moves include major acquisitions to add minimally invasive platforms, capital raises to scale robotic waterjet therapy, and commercialization of MRI guided transurethral ultrasound systems. 'Medtronic', 'Boston Scientific', 'Olympus Corporation', 'Teleflex', 'KARL STORZ', 'B. Braun Melsungen AG', 'Cook Medical', 'Richard Wolf GmbH', 'Stryker Corporation', 'Conmed Corporation', 'Ethicon', 'Endo Logic', 'Merit Medical Systems', 'PENTAX Medical', 'Becton Dickinson', 'Nuvectra Corporation', 'Apyx Medical', 'MAXX Medical', 'Standard Textile', 'Uroplasty, Inc.'
The growing proportion of older adults globally has expanded the pool of men susceptible to benign prostatic hyperplasia and related urinary symptoms, which in turn raises clinical demand for interventions such as transurethral resection of the prostate. As primary care screening and specialist referrals become more common, clinicians rely on established surgical treatments for symptom relief and quality of life restoration, creating sustained procedural volumes, steady clinician familiarity, and predictable demand patterns that support broader market expansion and investment in service delivery.
Minimally Invasive Technology: Adoption of less invasive surgical platforms is reshaping provider preferences and procedural pathways, driven by benefits in patient recovery, reduced perioperative disruption, and faster functional improvement. Surgeons increasingly favor technologies that balance tissue preservation with effective symptom relief, prompting manufacturers to refine energy delivery and ergonomic designs. This trend encourages investment in clinician training, cross-disciplinary collaboration, and outpatient procedural models, creating opportunities for differentiated device portfolios and partnerships focused on broader workflow integration and sustained patient quality of life improvements.
As per transurethral resection of the prostate market regional outlook, dominance in North America comes from a convergence of strengths in three areas: clinical, commercial, and regulatory.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
